Link Pharma Chem quarterly results and financials

Link Pharma Chem (BSE 524748)₹25.45−0.20%(9 Nov 2026 close)Commodity Chemicals

Key facts

In the Jun 2026 quarter (standalone), Link Pharma Chem reported sales of ₹8.79 Cr, up 12.4% from Jun 2025, and net profit of ₹0.33 Cr, down 19.5% year on year. For the year to Mar 2026, sales were ₹27.46 Cr and net profit ₹0.07 Cr.

Sales (Jun 2026): ₹8.79 Cr
Net profit (Jun 2026): ₹0.33 Cr
Sales (FY Mar 2026): ₹27.46 Cr
Net profit (FY Mar 2026): ₹0.07 Cr
EPS (Jun 2026): ₹0.71
Borrowings (Mar 2026): ₹7.34 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Link Pharma Chem quarterly results

₹ crore unless stated; each column is a quarter.

Link Pharma Chem Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	6.06	7.95	8.04	8.86	4.81	5.35	6.46	7.82	6.30	6.74	6.60	8.79
Expenses	6.94	7.68	7.14	8.32	5.11	5.24	6.70	7.19	5.97	6.06	6.85	8.35
Operating Profit	−0.89	0.29	0.92	0.56	−0.31	0.12	−0.24	0.65	0.35	0.70	−0.25	0.46
OPM %	−14.6%	3.5%	11.3%	6.2%	−6.3%	2.1%	−3.6%	8.2%	5.4%	10.2%	−3.7%	5.1%
Other Income	−0.04	0.38	−0.02	0.26	0.35	−0.57	0.11	0.22	0.04	−0.19	0.14	0.34
Interest	0.21	0.24	0.20	0.21	0.22	0.20	0.13	0.09	0.12	0.13	0.14	0.15
Depreciation	0.25	0.26	0.24	0.23	0.23	0.23	0.23	0.23	0.24	0.24	0.24	0.26
Profit before tax	−1.40	0.16	0.47	0.37	−0.40	−0.91	−0.50	0.52	0.02	0.11	−0.50	0.40
Tax %	−26.6%	−46.6%	45.7%	16.7%	−20.5%	−24.4%	−26.5%	21.6%	0.0%	40.1%	−16.3%	18.0%
Net Profit	−1.01	0.23	0.25	0.29	−0.30	−0.66	−0.36	0.41	0.01	0.06	−0.40	0.33
EPS (Rs)	−2.29	0.49	0.58	0.67	−0.69	−1.50	−0.78	0.89	0.04	0.15	−0.91	0.71

Link Pharma Chem profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Link Pharma Chem Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	12.36	16.12	23.55	24.54	25.51	34.83	53.61	38.81	29.94	25.46	27.46	28.43
Expenses	12.19	13.59	20.81	22.53	22.13	31.76	50.15	36.14	30.65	25.36	26.05	27.23
Operating Profit	0.20	2.55	2.79	2.03	3.43	3.15	3.55	2.73	−0.66	0.14	1.46	1.26
OPM %	1.5%	15.7%	11.8%	8.2%	13.4%	9.0%	6.6%	7.0%	−2.2%	0.5%	5.3%	4.4%
Other Income	2.38	−0.44	0.06	0.18	−0.68	−0.16	0.45	−0.14	0.65	0.18	0.19	0.33
Interest	0.90	0.81	0.61	0.38	0.35	0.43	0.44	0.75	0.88	0.77	0.52	0.54
Depreciation	0.92	0.82	0.85	0.88	0.92	0.86	0.92	0.91	1.02	0.93	0.97	0.98
Profit before tax	0.75	0.49	1.38	0.94	1.45	1.69	2.63	0.90	−1.92	−1.41	0.15	0.03
Tax %	20.3%	54.2%	17.6%	29.1%	34.1%	35.2%	28.3%	27.0%	−28.7%	−26.4%	42.9%	—
Exceptional items	2.01	0.00	0.00	0.00	−1.01	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	0.60	0.24	1.14	0.65	0.96	1.09	1.89	0.64	−1.35	−1.04	0.07	0.00
EPS (Rs)	1.32	0.51	2.53	1.48	2.13	2.42	4.22	1.45	−3.05	−2.31	0.17	−0.01
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Link Pharma Chem balance sheet

₹ crore, at each year end.

Link Pharma Chem Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4.43	4.43	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45
Reserves	3.94	4.53	4.17	5.36	5.95	7.01	8.15	10.06	10.62	9.30	8.24	8.37
Borrowings	10.84	5.43	4.74	2.72	2.65	3.57	3.68	6.41	8.79	9.25	5.80	7.34
Other Liabilities	7.37	3.48	3.81	4.69	4.99	3.98	9.82	8.09	8.67	3.00	4.85	4.86
Total Liabilities	26.58	17.87	17.17	17.22	18.04	19.01	26.10	29.01	32.53	26.00	23.34	25.02
Fixed Assets	17.53	10.14	9.58	9.77	9.15	8.82	8.72	8.80	9.01	9.95	9.29	10.39
CWIP	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.20	0.00	0.00	0.00	0.00
Investments	0.03	0.03	0.04	0.04	0.04	0.04	0.04	4.53	3.65	2.94	2.07	2.48
Other Assets	9.02	7.70	7.55	7.41	8.43	10.15	17.34	15.48	19.87	13.11	11.98	12.15
Inventories	3.74	3.66	4.26	2.62	2.86	1.62	2.49	4.75	12.24	6.20	5.73	5.01
Trade receivables	3.08	2.34	2.19	3.19	3.05	5.00	5.56	5.38	3.64	5.16	5.03	5.29
Cash & equivalents	1.20	0.26	0.17	0.17	0.19	2.04	4.85	0.87	0.19	0.08	0.05	0.62
Total Assets	26.58	17.87	17.17	17.22	18.04	19.01	26.10	29.01	32.53	26.00	23.34	25.02

Link Pharma Chem cash flow

₹ crore, for each year.

Link Pharma Chem Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	5.12	−3.90	2.22	3.78	1.35	2.94	4.83	−1.25	−1.70	−0.02	2.68	2.14
Cash from investing activity	−3.26	8.70	−0.72	−1.14	−0.95	−1.65	−2.15	−4.96	−0.07	0.40	1.52	−2.65
Cash from financing activity	−0.88	−5.76	−1.49	−2.64	−0.47	0.56	−0.34	2.28	1.62	−0.42	−4.22	1.00
Net cash flow	1.00	−0.95	0.03	0.00	−0.06	1.86	2.36	−3.96	−0.18	−0.04	0.00	0.49
Capex	3.28	1.94	0.92	1.16	0.87	1.70	1.80	1.15	0.88	0.94	0.25	2.09
Free cash flow	1.83	4.79	1.36	2.62	0.48	1.26	3.14	−2.02	−2.59	−0.85	2.42	0.04
CFO / OP %	−658.0%	−2,005.0%	92.0%	147.0%	77.0%	83.0%	169.0%	−17.0%	−48.0%	−52.0%	2,046.0%	150.0%

Link Pharma Chem ratios

Working-capital days and returns, by year.

Link Pharma Chem Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	64	69	49	49	45	72	58	37	34	63	72	70
Inventory days	126	278	287	98	94	61	52	49	210	137	168	171
Days payable	95	82	203	124	109	111	141	45	113	39	101	111
Cash conversion cycle	94	265	132	22	29	21	−31	39	131	160	138	130
Working capital days	−46	−6	1	33	32	52	11	15	28	6	16	−6
ROCE %	−8.7%	−3.6%	13.1%	15.5%	10.4%	18.8%	14.7%	13.2%	6.8%	−4.8%	−3.0%	3.5%

Link Pharma Chem: frequently asked questions

What are the latest quarterly results of Link Pharma Chem?

For the Jun 2026 quarter, Link Pharma Chem reported sales of ₹8.79 Cr, up 12.4% year on year and net profit of ₹0.33 Cr, down 19.5% year on year. The operating margin was 5.1%.

What is the annual revenue of Link Pharma Chem?

Link Pharma Chem's sales for the year to Mar 2026 were ₹27.46 Cr; over the last twelve months they were ₹28.43 Cr.

What is the net profit of Link Pharma Chem?

Net profit for the year to Mar 2026 was ₹0.07 Cr, and ₹0 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.01.

How much debt does Link Pharma Chem have?

Link Pharma Chem reported borrowings of ₹7.34 Cr at Mar 2026, against cash and equivalents of ₹0.62 Cr.

What is the free cash flow of Link Pharma Chem?

Cash from operations was ₹2.14 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.04 Cr.

Loading…